Vaccines, Blood & Biologics

Comvax (Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) & Hepatitis B Vaccine (Recombinant)) - Discontinued

STN: BL 103623
Proper Name: Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine
Tradename: COMVAX
Manufacturer:  Merck & Co., Inc, License #0002
Indication:  COMVAX is indicated for vaccination against invasive disease caused by Haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis B virus in infants 6 weeks to 15 months of age born of HBsAg negative mothers. 


Supporting Information

Page Last Updated: 07/10/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.